Herein, we report the identification of NTRK2 gene rearrangement by initial RNA-based NGS, with the efficacy of larotrectinib treatment in an adult patient with a sarcoma harboring STRN-NTRK2 fusions. The gene discussed is STRN; the disease is sarcoma.